Annexon Inc (ANNX)
7.255
+0.16
(+2.33%)
USD |
NASDAQ |
Nov 05, 16:00
7.255
0.00 (0.00%)
After-Hours: 18:45
Annexon Total Assets (Quarterly): 406.08M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 406.08M |
| March 31, 2024 | 304.07M |
| December 31, 2023 | 297.67M |
| September 30, 2023 | 203.82M |
| June 30, 2023 | 233.01M |
| March 31, 2023 | 268.78M |
| December 31, 2022 | 285.10M |
| September 30, 2022 | 312.72M |
| June 30, 2022 | 220.70M |
| March 31, 2022 | 250.57M |
| Date | Value |
|---|---|
| December 31, 2021 | 287.04M |
| September 30, 2021 | 310.16M |
| June 30, 2021 | 331.78M |
| March 31, 2021 | 333.12M |
| December 31, 2020 | 355.95M |
| September 30, 2020 | 375.61M |
| June 30, 2020 | 131.09M |
| March 31, 2020 | 39.51M |
| December 31, 2019 | 49.90M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
39.51M
Minimum
Mar 2020
406.08M
Maximum
Jun 2024
262.98M
Average
287.04M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Arbutus Biopharma Corp | 160.04M |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 45.01M |
| Shareholders Equity (Quarterly) | 361.08M |